These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 21688213

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Topical corticosteroids in atopic dermatitis and the risk of glaucoma and cataracts.
    Haeck IM, Rouwen TJ, Timmer-de Mik L, de Bruin-Weller MS, Bruijnzeel-Koomen CA.
    J Am Acad Dermatol; 2011 Feb; 64(2):275-81. PubMed ID: 21122943
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Osteonecrosis of the femoral and humeral heads after intraarticular corticosteroid injections.
    Laroche M, Arlet J, Mazieres B.
    J Rheumatol; 1990 Apr; 17(4):549-51. PubMed ID: 2348435
    [Abstract] [Full Text] [Related]

  • 11. [Ischemic osteonecrosis of the femur and humerus heads due to corticosteroid treatment in the child].
    Hervé J, de Gouyon F, Bonnet-Gajdos M, Lasfargues G.
    Arch Fr Pediatr; 1978 Apr; 35(4):420-3. PubMed ID: 686951
    [No Abstract] [Full Text] [Related]

  • 12. One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: A randomized, double-blind, comparative trial.
    Mandelin J, Remitz A, Virtanen H, Reitamo S.
    Acta Derm Venereol; 2010 Mar; 90(2):170-4. PubMed ID: 20169301
    [Abstract] [Full Text] [Related]

  • 13. [Non adherence and topical steroids].
    Aubert H, Barbarot S.
    Ann Dermatol Venereol; 2012 Jan; 139 Suppl 1():S7-12. PubMed ID: 22305285
    [Abstract] [Full Text] [Related]

  • 14. The proton pump inhibitor, lansoprazole, prevents the development of non-traumatic osteonecrosis of the femoral head: an experimental and prospective clinical trial.
    Kosukegawa I, Okazaki S, Yamamoto M, Nagoya S, Suzuki C, Shimizu J, Takahashi H, Yamashita T.
    Eur J Orthop Surg Traumatol; 2020 May; 30(4):713-721. PubMed ID: 31938894
    [Abstract] [Full Text] [Related]

  • 15. Corticosteroid dose increase is a risk factor for nonalcoholic fatty liver disease and contralateral osteonecrosis of the femoral head: a case report.
    Shimizu H, Shimizu T, Takahashi D, Asano T, Arai R, Takakuwa Y, Iwasaki N.
    BMC Musculoskelet Disord; 2019 Feb 19; 20(1):88. PubMed ID: 30782153
    [Abstract] [Full Text] [Related]

  • 16. [Steroid induced early changes of the femoral head in man--histological study of autopsied cases].
    Uno K, Kawai K, Hirohata K, Ito H.
    Ryumachi; 1991 Jun 19; 31(3):282-9. PubMed ID: 1948447
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ocular side-effects of topical corticosteroids: what a dermatologist needs to know.
    Daniel BS, Orchard D.
    Australas J Dermatol; 2015 Aug 19; 56(3):164-9. PubMed ID: 25754554
    [Abstract] [Full Text] [Related]

  • 19. Tacrolimus ointment: new preparation. Too many unknowns.
    Prescrire Int; 2004 Jun 19; 13(71):86-9. PubMed ID: 15233141
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.